Effect of Cisplatin-Induced Acute Renal Failure on Bioavailability and Intestinal Secretion of Quinolone Antibacterial Drugs in Rats

Pharmaceutical Research

Volumn 21, Issue 2, 2004, Pages 330-338

  Yamaguchi, Hiroaki ^a   Yano, Ikuko ^a   Saito, Hideyuki ^a   Inui, Ken Ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Acute renal failure; Intestinal secretion; P glycoprotein; Quinolones; Transport

Indexed keywords

CIPROFLOXACIN; CISPLATIN; GLYCOPROTEIN P; GREPAFLOXACIN; LEVOFLOXACIN; MULTIDRUG RESISTANCE PROTEIN 2; ORGANIC ANION TRANSPORTER; ORGANIC CATION TRANSPORTER; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DRUG BILE LEVEL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG TRANSPORT; DRUG URINE LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BILE DUCTS; BIOLOGICAL AVAILABILITY; BLOTTING, WESTERN; CACO-2 CELLS; CIPROFLOXACIN; CISPLATIN; DUODENUM; FLUOROQUINOLONES; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; MALE; OFLOXACIN; PIPERAZINES; RATS; RATS, WISTAR; TIME FACTORS;

EID: 1242314678     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAM.0000016247.44589.f1     Document Type: Article

References (30)

1. J. S. Wolfson and D. C. Hooper. Fluoroquinolone antibacterial agents. Clin. Microbiol. Rev. 2:378-424 (1989).
2. F. Sörgel, U. Jaehde, K. G. Naber, and U. Stephan. Pharmacokinetics disposition of quinolones in human body fluids and tissues. Clin. Pharmacokinet. 16(Suppl. 1):5-24 (1989).
3. C. Efthymiopoulos, S. L. Bramer, and A. Maroli. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males. Clin. Pharmacokinet. 33(Suppl. 1):1-8 (1997).
4. D. N. Fish and A. T. Chow. The clinical pharmacokinetics of levofloxacin. Clin. Pharmacokinet. 32:101-119 (1997).
5. F. Sörgel, K. G. Naber, U. Jaehde, A. Reiter, R. Seelman, and G. Sigl. Gastrointestinal secretion of ciprofloxacin. Am. J. Med. 87:62S-65S (1989).
6. G. R. Granneman, R. Braeckman, J. Kraut, S. Shupien, and J. C. Craft. Temafloxacin pharmacokinetics in subject with normal and impaired renal function. Antimicrob. Agents Chemother. 35:2345-2351 (1991).
7. H. Yamaguchi, I. Yano, Y. Hashimoto, and K. Inui. Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2. J. Pharmacol. Exp. Ther. 295:360-366 (2000).
8. K. Naruhashi, I. Tamai, N. Inoue, H. Muraoka, Y. Sai, N. Suzuki, and A. Tsuji. Active intestinal secretion of new quinolone antimicrobials and the partial contribution of P-glycoprotein. J. Pharm. Pharmacol. 53:699-709 (2001).
9. M. E. Cavet, M. West, and N. L. Simmons. Fluoroquinolone (ciprofloxacin) secretion by human intestinal epithelial (Caco-2) cells. Br. J. Pharmacol. 121:1567-1578 (1997).
10. N. M. Griffiths, B. H. Hirst, and N. L. Simmons. Active intestinal secretion of the fluoroquinolone antibacterials ciprofloxacin, norfloxacin and pefloxacin; a common secretory pathway? J. Pharmacol. Exp. Ther. 269:496-502 (1994).
11. S. Dautrey, K. Felice, A. Petiet, B. Lacour, C. Carbon, and R. Farinotti. Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates. Br. J. Pharmacol. 127:1728-1734 (1999).
12. J. Fabre and L. Balant. Renal failure, drug pharmacokinetics and drug action. Clin. Pharmacokinet. 1:99-120 (1976).
13. H. Katayama, J. Fujiwara, M. Yasuhara, K. Okumura, and R. Hon. Increased availability of propranolol in rats with uranyl nitrate-induced acute renal failure. J. Pharmacobiodyn. 7:536-544 (1984).
14. H. Okabe, Y. Hashimoto, and K. Inui. Pharmacokinetics and bioavailability of tacrolimus in rats with experimental renal dysfunction. J. Pharm. Pharmacol. 52:1467-1472 (2000).
15. W. J. Tilstone and A. Fine. Furosemide kinetics in renal failure. Clin. Pharmacol. Ther. 23:644-650 (1978).
16. R. Rohwedder, T. Bergan, S. B. Thorsteinsson, and H. Scholl. Transintestinal elimination of ciprofloxacin. Chemotherapy 36: 77-84 (1990).
17. S. Dautrey, L. Rabbaa, D. Laouari, B. Lacour, C. Carbon, and R. Farinotti. Influence of renal failure on intestinal clearance of ciprofloxacin in rats. Antimicrob. Agents Chemother. 43:678-680 (1999).
18. H. Akiyama, Y. Abe, M. Koike, K. Kyuushiki, N. Fujio, M. Odomi, F. Mukai, and K. Ohmori. Pharmacokinetics of grepafloxacin (I): absorption, distribution and excretion after oral administration of grepafloxacin in animals as determined by HPLC. Jpn. J. Chemother. 43(S-1):99-106 (1995).
19. 1: interaction with organic cation transporters in apical and basolateral membranes. J. Pharmacol. Exp. Ther. 276:1143-1148 (1996).
20. K. Naora, Y. Katagiri, N. Ichikawa, M. Hayashibara, and K. Iwamoto. A possible reduction in the renal clearance of ciprofloxacin by fenbufen in rats. J. Pharm. Pharmacol. 42:704-707 (1990).
21. K. Inui, M. Yamamoto, and H. Saito. Transepithelial transport of oral cephalosporins by monolayers of intestinal cell line Caco-2: specific transport systems in the apical and basolateral membranes. J. Pharmacol. Exp. Ther. 261:195-201 (1992).
22. 1). J. Pharmacol. Exp. Ther. 263:840-845 (1992).
23. 1. J. Pharmacol. Exp. Ther. 282:955-960 (1997).
24. S. Masuda, H. Saito, H. Nonoguchi, K. Tomita, and K. Inui. mRNA distribution and membrane localization of the OAT-K1 organic anion transporter in rat renal tubules. FEBS Lett. 407:127-131 (1997).
25. H. Yamaguchi, I. Yano, H. Saito, and K. Inui. Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo. J. Pharmacol. Exp. Ther. 300:1063-1069 (2002).
26. K. Naruhashi, I. Tamai, N. Inoue, H. Muraoka, Y. Sai, N. Suzuki, and A. Tsuji. Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats. Antimicrob. Agents Chemother. 46:344-349 (2002).
27. C. Veau, C. Leroy, H. Banide, D. Auchère, S. Tardivel, R. Farinotti, and B. Lacour. Effect of chronic renal failure on the expression and function of rat intestinal P-glycoprotein in drug excretion. Nephrol. Dial. Transplant. 16:1607-1614 (2001).
28. D. Laouari, R. Yang, C. Veau, I. Blanke, and G. Friedlander. Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure. Am. J. Physiol. 280:F636-F645 (2001).
29. Z. H. Huang, T. Murakami, A. Okochi, R. Yumoto, J. Nagai, and M. Takano. Expression and function of P-glycoprotein in rats with glycerol-induced acute renal failure. Eur. J. Pharmacol. 406:453-460 (2000).
30. M. Demeule, M. Brossard, and R. Béliveau. Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. Am. J. Physiol. 277:F832-F840 (1999).